We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $1.12B
1-Year Est. Return 390.6%
This Fund
S&P 500
This Quarter Est. Return
+39.52%
1 Year Est. Return
+390.6%
3 Year Est. Return
+6,011.55%
5 Year Est. Return
+59,317.81%
10 Year Est. Return
+26,738,247.09%
AUM
$866M
AUM Growth
-$31.6M
Cap. Flow
-$181M
Cap. Flow %
-20.86%
Top 10 Hldgs %
11.15%
Holding
394
New
126
Increased
23
Reduced
100
Closed
121

Top Buys

Rank Stock Value
1
MOG.A icon
Moog Inc Class A
MOG.A
+$8.18M
2
GLNG icon
Golar LNG
GLNG
+$6.78M
3
MOD icon
Modine Manufacturing
MOD
+$6.63M
4
MYRG icon
MYR Group
MYRG
+$6.49M
5
DAN icon
Dana Inc
DAN
+$6.19M

Sector Composition

Rank Sector Weight
1 Industrials 23.17%
2 Technology 23.07%
3 Healthcare 17.28%
4 Energy 12.86%
5 Consumer Discretionary 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSIS icon
351
OSI Systems
OSIS
$3.82B
-15,075
Closed -$3.85M
OUST icon
352
Ouster
OUST
$3.25B
-19,217
Closed -$416K
OWLT icon
353
Owlet
OWLT
$169M
-112,893
Closed -$1.83M
PESI icon
354
Perma-Fix Environmental Services
PESI
$412M
-64,784
Closed -$816K
PFSI icon
355
PennyMac Financial
PFSI
$4B
-37,009
Closed -$4.88M
PGEN icon
356
Precigen
PGEN
$2.32B
-405,001
Closed -$1.69M
PTCT icon
357
PTC Therapeutics
PTCT
$6.06B
-71,735
Closed -$5.45M
RDVT icon
358
Red Violet
RDVT
$1.11B
-30,147
Closed -$1.72M
REAL icon
359
The RealReal
REAL
$1.36B
-399,091
Closed -$6.3M
RIGL icon
360
Rigel Pharmaceuticals
RIGL
$782M
-26,983
Closed -$1.16M
RMBS icon
361
Rambus
RMBS
$10.8B
-60,957
Closed -$5.6M
RPID icon
362
Rapid Micro Biosystems
RPID
$84.8M
-77,182
Closed -$224K
RYTM icon
363
Rhythm Pharmaceuticals
RYTM
$8.1B
-57,327
Closed -$6.14M
SANM icon
364
Sanmina
SANM
$11.2B
-48,174
Closed -$7.23M
SF
365
Stifel
SF
$12.8B
-62,406
Closed -$5.21M
SGHT icon
366
Sight Sciences
SGHT
$456M
-163,866
Closed -$1.3M
SPRO icon
367
Spero Therapeutics
SPRO
$71.8M
-218,084
Closed -$508K
SPXC icon
368
SPX Corp
SPXC
$10.9B
-31,737
Closed -$6.35M
TARA icon
369
Protara Therapeutics
TARA
$233M
-103,611
Closed -$552K
TARS icon
370
Tarsus Pharmaceuticals
TARS
$3.07B
-72,922
Closed -$5.97M
TBPH icon
371
Theravance Biopharma
TBPH
$878M
-66,296
Closed -$1.24M
TCBX icon
372
Third Coast Bancshares
TCBX
$758M
-20,158
Closed -$766K
TLS icon
373
Telos
TLS
$324M
-105,100
Closed -$536K
STLN
374
Starling Oncology, Inc. Common Stock
STLN
$644M
-182,509
Closed -$650K
TRVI icon
375
Trevi Therapeutics
TRVI
$2.53B
-541,242
Closed -$6.78M

Similar funds

EAM Investors's Q1 2026 Portfolio in Review

As of Q1 2026, EAM Investors held 394 positions worth $866M, down 3.5% from $898M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

EAM Investors withdrew a net $181M in Q1 2026, closing 121 positions and reducing 100 holdings. Its most notable exit was Credo Technology Group, an estimated $11.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, EAM Investors opened a new position in Moog Inc Class A worth $7.82M.

  • EAM Investors's largest Q1 2026 buy was Moog Inc Class A: 26,715 shares worth $7.82M.
  • EAM Investors added most to Bloom Energy in Q1 2026, an estimated $3.21M increase.
  • EAM Investors's biggest Q1 2026 reduction was Sandisk, cutting an estimated $8.28M.
  • EAM Investors fully exited Credo Technology Group in Q1 2026, selling an estimated $11.3M.
  • EAM Investors's ten largest holdings make up 11% of its $866M portfolio in Q1 2026.
  • EAM Investors opened 126 new positions and closed 121 in Q1 2026.
  • EAM Investors's portfolio value fell 3.5% quarter-over-quarter to $866M.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.